"Andrew Iwach, M.D., Shan Lin, M.D, Terri Pickering, M.D. , Sunita Radhakrishan, M.D."

During the past decade, Glaucoma Center of San Francisco conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Glaucoma Center of San Francisco" #1 collaborator was "PharmaLogic Development, Inc." with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Glaucoma Center of San Francisco" are "Glaucoma" (1 trials), "Ocular Hypertension" (1 trials), "Pigment Dispersion Glaucoma" (1 trials), "Primary Open Angle Glaucoma" (1 trials) and "Primary Open Angle Glaucoma or Ocular Hypertension" (1 trials). Many other conditions were trialed in "Glaucoma Center of San Francisco" in a lesser frequency.

Most popular intervention types in "Glaucoma Center of San Francisco" are "Procedure" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "AR-13324 Ophthalmic Solution 0.02%" (1 trials), "AR-13324 Ophthalmic Solution 0.04%" (1 trials), "AR-13324 Ophthalmic Solution Placebo" (1 trials), "Glaucoma surgery- Bleb revision" (1 trials) and "Selective laser trabeculoplasty" (1 trials). Other intervention names were less common.

The vast majority of trials in "Glaucoma Center of San Francisco" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Glaucoma Center of San Francisco". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Glaucoma Center of San Francisco, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Glaucoma Center of San Francisco, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".